Page last updated: 2024-09-04

ezetimibe and Orphan Diseases

ezetimibe has been researched along with Orphan Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alméciga-Diaz, CJ; Garzón, R; Gorshkov, K; Guzman, E; Hidalgo, OA; Li, R; Olarte-Avellaneda, S; Pimentel-Vera, LN; Puentes-Tellez, MA; Rodríguez-López, A; Rojas-Rodriguez, AF; Zheng, W	1
Dembinski, T; Hatch, GM; Mymin, D; Salen, G; Triggs-Raine, B; Waggoner, DJ	1

Other Studies

2 other study(ies) available for ezetimibe and Orphan Diseases

Article	Year
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13 Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins	2019
The natural history of phytosterolemia: Observations on its homeostasis. Atherosclerosis, 2018, Volume: 269 Topics: Adolescent; Adult; Age Factors; Anticholesteremic Agents; Asymptomatic Diseases; ATP Binding Cassette Transporter, Subfamily G, Member 8; Biomarkers; Canada; Child; Child, Preschool; Cholesterol; Ezetimibe; Female; Genetic Predisposition to Disease; Homeostasis; Humans; Hypercholesterolemia; Infant; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Mutation; Phenotype; Phytosterols; Prevalence; Puberty; Rare Diseases; Risk Factors; Sitosterols; Time Factors; Treatment Outcome; United States; Young Adult	2018

Article

Year

Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.

Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13

Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins

2019

The natural history of phytosterolemia: Observations on its homeostasis.

Atherosclerosis, 2018, Volume: 269

Topics: Adolescent; Adult; Age Factors; Anticholesteremic Agents; Asymptomatic Diseases; ATP Binding Cassette Transporter, Subfamily G, Member 8; Biomarkers; Canada; Child; Child, Preschool; Cholesterol; Ezetimibe; Female; Genetic Predisposition to Disease; Homeostasis; Humans; Hypercholesterolemia; Infant; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Mutation; Phenotype; Phytosterols; Prevalence; Puberty; Rare Diseases; Risk Factors; Sitosterols; Time Factors; Treatment Outcome; United States; Young Adult

2018